Katalyst CRO ยท 1 month ago
Senior Clinical SAS Programmer
Katalyst CRO is a company focused on clinical research, and they are seeking a Senior Clinical SAS Programmer. The role involves representing the programming function in team meetings and developing CDISC-compliant datasets for regulatory submissions.
AnalyticsBiopharmaData ManagementHuman ResourcesQuality Assurance
Responsibilities
Developing CDISC-compliant datasets and corresponding documentation for electronic submission to regulatory agencies
Creating or reviewing software systems to generate displays of clinical study data as tables, listings, and graphs for electronic submission to regulatory agencies
Assisting statisticians by suggesting algorithms to address client analysis requests
Developing software validation procedures and test plans
Qualification
Required
Minimum years of experience in developing software for clinical trials using the SAS system
Skilled in programming with SAS. Knowledge of additional programming languages a plus
Good knowledge of statistics and drug development process
Experience as a lead programmer for NDAs/BLAs
Experience overseeing the work of internal contractors and external vendors (CROs)
Company
Katalyst CRO
Katalyst CRO | Advancing Healthcare & Life Sciences with Expert Research & Regulatory Solutions Katalyst Healthcare & Life Sciences (Katalyst CRO) is a Global Contract Research and Knowledge Process Outsourcing Organization (CRO) dedicated to driving innovation in research, regulatory compliance, and quality excellence for pharmaceutical, biotechnology, and medical device companies worldwide.
H1B Sponsorship
Katalyst CRO has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (37)
2024 (14)
2023 (24)
2022 (52)
2021 (54)
2020 (39)
Funding
Current Stage
Growth StageRecent News
2024-04-07
Company data provided by crunchbase